In pregnant women, the intestinal bacterial composition has been implicated in alterations in insulin, c-peptide, HOMA-IR, and hemoglobin A1C levels, as well as low-grade inflammatory responses, which lead to GDM manifestations [40,41,42]. This evidence concerns the gene INS and gestational diabetes.